Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ARYx amends IPO

ARYx (Fremont, Calif.) amended its IPO and hopes to sell

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE